KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Cash from Investing Activities (2016 - 2025)

Globus Medical (GMED) has disclosed Cash from Investing Activities for 15 consecutive years, with -$111.4 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 7.04% year-over-year to -$111.4 million, compared with a TTM value of -$355.0 million through Dec 2025, down 101.65%, and an annual FY2025 reading of -$355.0 million, down 101.65% over the prior year.
  • Cash from Investing Activities was -$111.4 million for Q4 2025 at Globus Medical, down from -$75.8 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $320.6 million in Q4 2023 and bottomed at -$299.1 million in Q2 2025.
  • Average Cash from Investing Activities over 5 years is -$35.7 million, with a median of -$30.8 million recorded in 2024.
  • The sharpest move saw Cash from Investing Activities tumbled 4726.93% in 2021, then soared 19069.23% in 2022.
  • Year by year, Cash from Investing Activities stood at -$243.8 million in 2021, then soared by 75.19% to -$60.5 million in 2022, then skyrocketed by 630.08% to $320.6 million in 2023, then plummeted by 132.48% to -$104.1 million in 2024, then fell by 7.04% to -$111.4 million in 2025.
  • Business Quant data shows Cash from Investing Activities for GMED at -$111.4 million in Q4 2025, -$75.8 million in Q3 2025, and -$299.1 million in Q2 2025.